Financials in USD. Standardized financial statements.
A compact view of how BIOLASE, Inc. turns revenue into operating income and net income.
| Metric | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $49.16M | $48.46M | $39.19M | $22.78M | $37.80M | $46.16M | $46.93M | $51.81M | $48.48M | $47.66M |
| Revenue Growth? | +1.4% | +23.7% | +72.0% | -39.7% | -18.1% | -1.6% | -9.4% | +6.9% | +1.7% | 0.0% |
| Cost of Revenue? | $32.44M | $32.55M | $22.66M | $16.61M | $23.51M | $29.26M | $31.80M | $31.50M | $32.52M | $29.48M |
| Gross Profit? | $16.72M | $15.91M | $16.53M | $6.17M | $14.29M | $16.89M | $15.13M | $20.31M | $15.95M | $18.17M |
| Gross Margin? | +34.0% | +32.8% | +42.2% | +27.1% | +37.8% | +36.6% | +32.2% | +39.2% | +32.9% | +38.1% |
| Operating Expenses? | $34.66M | $41.25M | $32.65M | $24.71M | $29.91M | $35.09M | $32.66M | $35.27M | $36.60M | $36.11M |
| Operating Income? | -$17.94M | -$25.34M | -$16.12M | -$18.54M | -$15.62M | -$20.89M | -$18.04M | -$14.96M | -$19.91M | -$17.94M |
| EBITDA? | -$15.44M | -$25.28M | -$13.47M | -$13.84M | -$14.76M | -$17.25M | -$16.33M | -$13.91M | -$19.77M | -$17.25M |
| Income Before Tax | -$20.60M | -$28.52M | -$16.09M | -$16.70M | -$17.90M | -$21.45M | -$17.43M | -$15.22M | -$20.10M | -$18.81M |
| Income Tax Expense | $31,000 | $109,000 | $65,000 | $128,000 | -$44,000 | $63,000 | -$582,000 | $151,000 | $178,000 | $112,000 |
| Net Income? | -$20.63M | -$28.63M | -$16.16M | -$16.83M | -$17.86M | -$21.52M | -$16.85M | -$15.37M | -$20.28M | -$18.93M |
| EPS? | $-16.14 | $-413.19 | $-273.41 | $-688.19 | $-1923.95 | $-2612.75 | $-2856.10 | $-3167.32 | $-4356.18 | $-5258.68 |
| Diluted EPS? | $-16.14 | $-413.19 | $-273.41 | $-688.19 | $-1923.95 | $-2612.75 | $-2856.10 | $-3167.32 | $-4356.18 | $-5258.68 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality